Such ECM modifications may offer insights into how the skin barrier and microenvironment mitigate pathogen-induced keratinocyte activation in acne pathogenesis, complementing the CLR-mediated pathways identified in this study [29,30,31]. This evidence concerns the gene DCLK3 and acne.